HIGHLIGHTS
- who: Yingying Song from the Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China Drug Discovery and Development have published the research: Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular docking, in the Journal: (JOURNAL)
- what: The authors used network pharmacology and molecular docking strategies to identify major active ingredients in and reveal its putative mechanism against human Six compounds quercetin cholesterol 3-epi-beta-sitosterol diosgenin medioresinol and solanocapsine were identified to be major active ingredients. In the present study, active components . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.